|
|  | |||
|
 |
home about contact disclaimer links member-login |
| |
 | ||||
 | ||||
 | ||||
 | ||||
 | ||||
 | ||||
   | ||||
 | |||||||||||||||||||
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
professionals · studies · colon.html | |
|
|
|
|
| |
|
Studies on Colon Carcinoma Whole body hyperthermia: Systemic multimodal cancer therapy (42°C) combined with 5-FU and Mitomycin in metastatic colorectal carcinoma Coordination: Prof. Dr. med. H. Riess Dr. med. B. Hildebrandt Medizinische Klinik Prof. Dr. med. P. Wust Klinik für Strahlenheilkunde Charité - Campus Virchow-Klinikum 13353 Berlin Tel: -49-30-450-53013 or 57023/57202 Whole body hyperthermia: Open, randomized, multicentric phase III trail of Oxaliplatin and 5-Fluorouracil/Leucovorin as second and third line therapy in locally advanced or metas-tatic, nonresectable colorectal carcinoma and documented progression within three months after high dose therapy with 5-Fluorouracil (25h)/Leucovorin (ARDALAN) or CPT-11 containing protocols. Coordination: Prof. Dr. med. S. Hegewisch-Becker Abt. für Onkologie und Hämatologie Universitätsklinik Eppendorf Hamburg Tel: +49-40-42803-3971 Regional Hyperthermia: Prospective phase I/II study of regional hyperthermia and radiotherapy of hepatic metastases in colorectal carcinoma. Coordination: Prof. Dr. med. M. Bamberg Dr. med. T. Hehr Abteilung für Strahlentherapie Universitätsklinikum Tübingen Tel: +49-7071-29-82166 | |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |